Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000632506 | SCV000753691 | uncertain significance | Neurofibromatosis, type 1 | 2022-04-07 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NF1 protein function. ClinVar contains an entry for this variant (Variation ID: 527591). This missense change has been observed in individual(s) with neurofibromatosis type 1 (PMID: 25074460). This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 895 of the NF1 protein (p.Met895Arg). |
Gene |
RCV004721503 | SCV005327259 | likely pathogenic | not provided | 2024-03-20 | criteria provided, single submitter | clinical testing | Exonic splice site variant reported to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease (PMID: 29290338); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25074460, 29290338, 35982159, 35982160) |